Memantine Ciclum

Memantine Hydrochloride, the active ingredient in Memantine Ciclum, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adults, helping to improve cognition and functional abilities.

GNH USA supplies Memantine Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Memantine Hydrochloride is used in the management of neurodegenerative conditions that involve glutamatergic excitotoxicity, primarily Alzheimer’s disease.

- Alzheimer’s disease (mild to moderate): improves cognitive function and daily living activities.

Memantine is generally well tolerated, but a range of adverse reactions have been reported.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue - Confusion - Hypertension

Serious or Rare Side Effects: - Seizures - Cardiac arrhythmias - Hepatic dysfunction - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe hypotension - Neuroleptic malignant‑like syndrome

When prescribing Memantine Ciclum, clinicians should consider several safety aspects.

- Renal impairment: assess kidney function and adjust dose if necessary. - History of seizures: monitor closely for increased seizure activity. - Cardiovascular disease: evaluate blood pressure and heart rhythm regularly. - Concomitant NMDA antagonists: avoid additive neuro‑psychiatric effects. - Pregnancy and lactation: safety unknown; use only if potential benefit justifies risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Memantine may interact with other medicines that affect the central nervous system or cardiovascular system.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism can increase CNS toxicity. - Ketamine: additive blockade may exacerbate neuropsychiatric effects. - High‑dose anticholinergics: may worsen confusion.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: memantine may blunt blood‑pressure‑lowering effects. - Diuretics: monitor electrolytes and blood pressure. - Other cognitive enhancers (e.g., donepezil): assess for synergistic benefits versus adverse events.